Anteris Technologies Global Corp. reported a $21.9 million net loss for Q1 2025, driven by increased R&D spending as it scales manufacturing and prepares pivotal trials for its DurAVR Transcatheter Heart Valve. The company’s recent $80 million IPO proceeds are being deployed to support these efforts and repay debt.
Fulcrum Lithium Ltd has successfully completed its IPO, raising $9.7 million, and commenced drilling at its Alkali Flats lithium project in Nevada, marking a significant step in its exploration journey.